BRIEF-Teva Pharmaceutical’s Q1 Non-GAAP EPS $1.20 – Reuters

BRIEF-Teva Pharmaceutical’s Q1 Non-GAAP EPS $1.20
Reuters
May 9 Teva Pharmaceutical Industries Ltd. * Teva reports first quarter 2016 results. * Teva Pharmaceutical Industries Ltd says generic medicines revenues in q1 of 2016 amounted to $2.2 billion, a decrease of 17%. * Teva Pharmaceutical Industries Ltd

Source: pharmaceutical – Google News

Sharing information is key – Pharmaceutical Business News UK. Social Commerce and Social Media Management playing a big part. Suaju Ltd